AxoGen (NASDAQ: AXGN) reported Q4 EPS of $0.07, $0.04 better than the analyst estimate of $0.03. Revenue for the quarter came in at $49.4 million versus the consensus estimate of $47.58 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.